1. Home
  2. AS vs DVA Comparison

AS vs DVA Comparison

Compare AS & DVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AS
  • DVA
  • Stock Information
  • Founded
  • AS 1950
  • DVA 1994
  • Country
  • AS Finland
  • DVA United States
  • Employees
  • AS N/A
  • DVA N/A
  • Industry
  • AS
  • DVA Misc Health and Biotechnology Services
  • Sector
  • AS
  • DVA Health Care
  • Exchange
  • AS NYSE
  • DVA Nasdaq
  • Market Cap
  • AS 13.3B
  • DVA 15.2B
  • IPO Year
  • AS 2024
  • DVA 1995
  • Fundamental
  • Price
  • AS $28.59
  • DVA $142.30
  • Analyst Decision
  • AS Buy
  • DVA Hold
  • Analyst Count
  • AS 14
  • DVA 5
  • Target Price
  • AS $26.07
  • DVA $154.40
  • AVG Volume (30 Days)
  • AS 2.8M
  • DVA 1.1M
  • Earning Date
  • AS 02-25-2025
  • DVA 02-13-2025
  • Dividend Yield
  • AS N/A
  • DVA N/A
  • EPS Growth
  • AS N/A
  • DVA 44.61
  • EPS
  • AS N/A
  • DVA 10.73
  • Revenue
  • AS $4,843,300,000.00
  • DVA $12,815,550,000.00
  • Revenue This Year
  • AS $21.01
  • DVA $4.69
  • Revenue Next Year
  • AS $14.98
  • DVA $3.54
  • P/E Ratio
  • AS N/A
  • DVA $13.27
  • Revenue Growth
  • AS 13.38
  • DVA 5.56
  • 52 Week Low
  • AS $10.11
  • DVA $122.65
  • 52 Week High
  • AS $34.00
  • DVA $179.60
  • Technical
  • Relative Strength Index (RSI)
  • AS 40.74
  • DVA 25.38
  • Support Level
  • AS $30.30
  • DVA $150.11
  • Resistance Level
  • AS $31.50
  • DVA $178.38
  • Average True Range (ATR)
  • AS 1.28
  • DVA 4.89
  • MACD
  • AS -0.40
  • DVA -4.14
  • Stochastic Oscillator
  • AS 8.88
  • DVA 3.47

About AS AMER SPORTS INC

Amer Sports manages a diverse portfolio of 10 outdoor and action sports brands that collectively generated revenue of $4.4 billion in 2023. Although primarily owned by the Chinese conglomerate Anta Sports, Amer operates with a degree of autonomy. In its rapidly expanding China business, the company is subject to closer oversight, but it manages its operations outside of China with relative independence. In 2023, the firm generates 40% of its revenue from the Americas, 33% from Europe, the Middle East, and Africa, 19% from China, and 7% from Asia-Pacific, excluding China.

About DVA DaVita Inc.

DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives about two thirds of U.S. sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.

Share on Social Networks: